Application Nr Approved Date Route Status External Links
ANDA202786 2013-04-22 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ropinirole Extended-Release Tablets Are Non-Ergoline Dopamine Agonist Indicated For The Treatment Of Parkinson’s Disease (1.1) 1.1 Parkinson's Disease Ropinirole Extended-Release Tablets Are Indicated For The Treatment Of Parkinson’s Disease.

All Formulated Excipients (5 Total)

Name Structure Kind Function Status
1. Silicon Dioxide SILICON DIOXIDE Unresolved AC-Anticaking agent , MISC-Miscellaneous , STAB-Stabilizer GRAS-Generally recognized as safe.
2. Hydrogenated Castor Oil HYDROGENATED CASTOR OIL Molecular
3. Hypromelloses HYPROMELLOSES Unresolved
4. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
5. Povidones POVIDONES Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ropinirole Hydrochloride ROPINIROLE HYDROCHLORIDE ZINC2041